Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.

Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.

Publication date: Aug 09, 2019

Ashida, A., Sakaizawa, K., Mikoshiba, A., Kiniwa, Y., and Okuyama, R. Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma. 23708. 2019 Acta Derm Venereol.

Concepts Keywords
Melanoma Biomarker
RTT
Melanoma
Cancer

Semantics

Type Source Name
disease MESH tumor
gene UNIPROT BRAF
pathway BSID Melanoma
disease DOID Melanoma
disease MESH Melanoma

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *